Keiko Sonoda1, Hiroshi Watanabe1, Takashi Hisamatsu2,3,4, Takashi Ashihara4, Seiko Ohno2,4, Hideki Hayashi4, Minoru Horie4, Tohru Minamino1. 1. Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. 2. Center for Epidemiologic Research in Asia, Shiga University of Medical Science, Otsu, Japan. 3. Department of Public Health, Shiga University of Medical Science, Otsu, Japan. 4. Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Japan.
Abstract
BACKGROUND: J wave, or early repolarization has recently been associated with an increased risk of lethal arrhythmia and sudden death, both in idiopathic ventricular fibrillation and in the general population. Hypercalcemia is one of the causes of J point and ST segment elevation, but the relationship has not been well studied. The aim of this study was to examine the effects of hypercalcemia on J point elevation. METHODS: Electrocardiographic findings were compared in 89 patients with hypercalcemia and 267 age- and sex-matched healthy controls with normocalcemia. The association of J point elevation with arrhythmia events in patients with hypercalcemia was also studied. RESULTS: The PR interval and the QRS duration were longer in patients with hypercalcemia than in normocalcemic controls. Both the QT and the corrected QT intervals were shorter in patients with hypercalcemia compared with normocalcemic controls. Conduction disorders, ST-T abnormalities, and J point elevation were more common in patients with hypercalcemia than normocalcemic controls. Following the resolution of hypercalcemia, the frequency of J point elevation decreased to a level similar to that noted in controls. During hospitalization, no arrhythmia event occurred in patients with hypercalcemia. CONCLUSION: Hypercalcemia was associated with J point elevation.
BACKGROUND: J wave, or early repolarization has recently been associated with an increased risk of lethal arrhythmia and sudden death, both in idiopathic ventricular fibrillation and in the general population. Hypercalcemia is one of the causes of J point and ST segment elevation, but the relationship has not been well studied. The aim of this study was to examine the effects of hypercalcemia on J point elevation. METHODS: Electrocardiographic findings were compared in 89 patients with hypercalcemia and 267 age- and sex-matched healthy controls with normocalcemia. The association of J point elevation with arrhythmia events in patients with hypercalcemia was also studied. RESULTS: The PR interval and the QRS duration were longer in patients with hypercalcemia than in normocalcemic controls. Both the QT and the corrected QT intervals were shorter in patients with hypercalcemia compared with normocalcemic controls. Conduction disorders, ST-T abnormalities, and J point elevation were more common in patients with hypercalcemia than normocalcemic controls. Following the resolution of hypercalcemia, the frequency of J point elevation decreased to a level similar to that noted in controls. During hospitalization, no arrhythmia event occurred in patients with hypercalcemia. CONCLUSION:Hypercalcemia was associated with J point elevation.
Authors: Mehmood Zeb; Daniel B McKenzie; Bushra Naheed; Tasso Gazis; John M Morgan; Andrew D Staniforth Journal: Resuscitation Date: 2010-06-02 Impact factor: 5.262
Authors: Sahil Mehta; Anoop C Parameswaran; Allan Greenspan; Vincent M Figueredo Journal: Pacing Clin Electrophysiol Date: 2009-08-27 Impact factor: 1.976
Authors: Jani T Tikkanen; Olli Anttonen; M Juhani Junttila; Aapo L Aro; Tuomas Kerola; Harri A Rissanen; Antti Reunanen; Heikki V Huikuri Journal: N Engl J Med Date: 2009-11-16 Impact factor: 91.245
Authors: Charles Antzelevitch; Pedro Brugada; Martin Borggrefe; Josep Brugada; Ramon Brugada; Domenico Corrado; Ihor Gussak; Herve LeMarec; Koonlawee Nademanee; Andres Ricardo Perez Riera; Wataru Shimizu; Eric Schulze-Bahr; Hanno Tan; Arthur Wilde Journal: Circulation Date: 2005-01-17 Impact factor: 29.690
Authors: Michel Haïssaguerre; Nicolas Derval; Frederic Sacher; Laurence Jesel; Isabel Deisenhofer; Luc de Roy; Jean-Luc Pasquié; Akihiko Nogami; Dominique Babuty; Sinikka Yli-Mayry; Christian De Chillou; Patrice Scanu; Philippe Mabo; Seiichiro Matsuo; Vincent Probst; Solena Le Scouarnec; Pascal Defaye; Juerg Schlaepfer; Thomas Rostock; Dominique Lacroix; Dominique Lamaison; Thomas Lavergne; Yoshifusa Aizawa; Anders Englund; Frederic Anselme; Mark O'Neill; Meleze Hocini; Kang Teng Lim; Sebastien Knecht; George D Veenhuyzen; Pierre Bordachar; Michel Chauvin; Pierre Jais; Gaelle Coureau; Genevieve Chene; George J Klein; Jacques Clémenty Journal: N Engl J Med Date: 2008-05-08 Impact factor: 91.245
Authors: Latoya A Stewart; Gabrielle K Steinl; Bernice L Huang; Catherine McManus; James A Lee; Jennifer H Kuo; Marcella D Walker Journal: J Clin Endocrinol Metab Date: 2022-03-24 Impact factor: 5.958